NASDAQ: ARAY
Accuray Incorporated
Healthcare · Medical - Devices
Market Cap
$41.39M
52w High
$2.10
52w Low
$0.25
P/E
-0.94
Volume
916.12K
Outstanding Shares
118.96M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 71.72% over the last year. Revenue declined 7.88% over the trailing twelve months. Operating margin moved from 2.24% to -3.53%. Free cash flow declined 264.88% over the trailing twelve months.
What the market seems to be pricing
The market is reacting to weaker business momentum more than just compressing the valuation multiple. Even if the shares already screen cheap on P/S, investors are still discounting lower future earnings power.
What would invalidate this read
Operating margin stands at -3.53%. Revenue declined 7.88% — this read reverses if that trend stabilizes. Free cash flow fell 264.88% — a return toward positive territory would undermine the deterioration thesis. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
8
Buy
4
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 19, 2026
Q3 FY26 · EPS est -$0.03 · Revenue est $105.82M
View